Maki, Kevin C.
Kirkpatrick, Carol F.
Cheeley, Mary Katherine
Jacobson, Terry A.
Article History
Accepted: 2 November 2024
First Online: 18 November 2024
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Financial interests: KCM is an employee of Midwest Biomedical Research and has received consulting fees and/or research grant support from 89Bio; Acasti Pharma; Beren Pharmaceuticals; Eli Lilly & Co.; NewAmsterdam Pharma; Matinas BioPharma; NorthSea Therapeutics; Novo Nordisk; Pharmavite. CFK is an employee of Midwest Biomedical Research, which has received research funding and consulting fees from food and pharmaceutical companies; no other disclosures. MKC is a sub-investigator for clinical trials funded by Novartis and Eli Lilly and Company and a consultant and advisory board member for Regeneron and Novartis. TAJ received consulting fees from Amgen, Regeneron, Astra Zeneca, and Novartis.